BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37646013)

  • 21. Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.
    Herrera-Mullar J; Fulk K; Brannan T; Yussuf A; Polfus L; Richardson ME; Horton C
    Genet Med; 2023 Nov; 25(11):100937. PubMed ID: 37466057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
    PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of Shelterin subunit genes in zebrafish results in distinct outcomes.
    Ma J; Tang D; Gao P; Liang S; Zhang R
    Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):22-29. PubMed ID: 35667242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
    Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
    Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.
    Sasa GS; Ribes-Zamora A; Nelson ND; Bertuch AA
    Clin Genet; 2012 May; 81(5):470-8. PubMed ID: 21477109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
    Gong Y; Stock AJ; Liu Y
    Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal findings and a novel TINF2 mutation in Revesz syndrome: Clinical and molecular correlations with pediatric retinal vasculopathies.
    Gupta MP; Talcott KE; Kim DY; Agarwal S; Mukai S
    Ophthalmic Genet; 2017; 38(1):51-60. PubMed ID: 28095086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2.
    Vulliamy T; Beswick R; Kirwan MJ; Hossain U; Walne AJ; Dokal I
    Clin Genet; 2012 Jan; 81(1):76-81. PubMed ID: 21199492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
    Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
    Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
    J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.
    Müller C; Krunic M; Wendt J; von Haeseler A; Okamoto I
    G3 (Bethesda); 2018 May; 8(5):1475-1480. PubMed ID: 29523635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to Tumorigenesis.
    Liu J; Yu C; Hu X; Kim JK; Bierma JC; Jun HI; Rychnovsky SD; Huang L; Qiao F
    Cell Rep; 2015 Sep; 12(12):2169-80. PubMed ID: 26365187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Germline Mutation in the
    Srivastava A; Miao B; Skopelitou D; Kumar V; Kumar A; Paramasivam N; Bonora E; Hemminki K; Försti A; Bandapalli OR
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492864
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Kocheva SA; Gjorgjievska M; Martinova K; Antevska-Trajkova Z; Jovanovska A; Plaseska-Karanfilska D
    Balkan J Med Genet; 2021 Nov; 24(2):89-93. PubMed ID: 36249522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.
    Vulliamy TJ; Kirwan MJ; Beswick R; Hossain U; Baqai C; Ratcliffe A; Marsh J; Walne A; Dokal I
    PLoS One; 2011; 6(9):e24383. PubMed ID: 21931702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.
    Alder JK; Stanley SE; Wagner CL; Hamilton M; Hanumanthu VS; Armanios M
    Chest; 2015 May; 147(5):1361-1368. PubMed ID: 25539146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
    Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
    Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis.
    Hoffman TW; van der Vis JJ; van Oosterhout MF; van Es HW; van Kessel DA; Grutters JC; van Moorsel CH
    Case Rep Pulmonol; 2016; 2016():1310862. PubMed ID: 27088026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length variation and expression analysis of shelterin complex genes during gallbladder carcinogenesis.
    Poojary SS; Mishra G; Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    J Cancer Res Ther; 2017; 13(2):235-239. PubMed ID: 28643740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere dynamics and homeostasis in a transmissible cancer.
    Ujvari B; Pearse AM; Taylor R; Pyecroft S; Flanagan C; Gombert S; Papenfuss AT; Madsen T; Belov K
    PLoS One; 2012; 7(8):e44085. PubMed ID: 22952882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.